Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are approved for the treatment of type 2 diabetes and obesity
Foundayo is a genuine small-molecule oral GLP-1, not the same as compounded oral peptide tablets, which lack published human absorption data
The increasing presence of type 2 diabetes in youth is creating a longterm demand path for advanced therapies, reinforcing the relevance of incretinbased drugs across age groups
By binding to GLP-1 receptors, Ozempic promotes insulin secretion, reduces glucagon production (which lowers blood sugar), and slows down stomach emptying, leading to decreased appetite
WHAT'S COMING CVS Caremark Coverage Outlook for 2026 CVS Caremark has confirmed the Zepbound formulary exclusion continues through 2026 with "no new GLP-1 formulary changes" planned
US$ 28.69
US$ 29.26
US$ 23.34
US$ 27.95
US$ 22.98
US$ 22.91
US$ 28.11
US$ 29.79
US$ 23.97
US$ 23.76
US$ 22.64
